Equity Profile

BLLN

BillionToOne, Inc.

Health CareHealth Care Services$5.7B

May6Wed

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

BillionToOne, Inc. Beats on EPS, Stock Up 1.88%

Metric	Actual	Expected	Surprise
EPS	$0.34	$0.06	+3300.00%
Revenue	—	$97M	—

management commentary, guidance changes, and full analysis available with Pro.

BillionToOne, Inc. Beats on EPS, Stock Up 1.88%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.34	$0.06	+3300.00%
Revenue	—	$97M	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

BillionToOne, Inc. reported a strong earnings surprise with EPS significantly exceeding expectations, which likely contributed to the stock's 1.88% increase. However, the lack of revenue data and guidance leaves some uncertainty about future performance. Investors may be encouraged by the EPS result but will need more information to assess the overall health of the company.

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$0.06

Revenue

Revenue growth is crucial for assessing the company's overall performance and market demand for its services.

$97M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services. The company is notable for its advancements in genetic testing, which can impact patient care and treatment options significantly.

Earnings Scorecard·Last 3Q

EPS Beat Streak

EPS Beat Rate

67%

Avg EPS Surprise

+1110.58%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In the last quarter, BillionToOne reported an EPS of $0.11, significantly beating expectations. However, the stock experienced a decline of 2.78% the following day.

Management Promises & Guidance

Management committed to enhancing their genetic testing capabilities.
They expressed intentions to expand their market reach.
They highlighted plans to improve operational efficiency.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about BillionToOne's upcoming earnings, with expectations for modest growth in both EPS and revenue. The market is keen to see if the company can maintain its recent performance.

Bull Case

If BillionToOne exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its services and lead to a positive stock reaction.

Bear Case

Conversely, if the company misses on EPS or revenue, it may raise concerns about its growth trajectory and impact investor confidence.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.06

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue

$97M

Revenue growth is crucial for assessing the company's overall performance and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.06?

A beat on EPS could reinforce investor confidence and support a bullish outlook for the company.

What revenue figures will BillionToOne report relative to the $97M consensus?

Revenue performance is critical for understanding market demand and growth potential, influencing future investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the company's growth potential, particularly if recent advancements in genetic testing lead to higher demand than anticipated.

Supporting Evidence

The last quarter's EPS surprise of +69.23% indicates stronger-than-expected performance.

The options market is pricing in a significant move, suggesting that traders expect volatility and potential upside.

BillionToOne's recent commitments to enhance testing capabilities could drive future growth.

Key Risk

If revenue comes in below $94M, it could challenge the optimistic growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's focus is on whether BillionToOne can sustain its growth momentum and meet or exceed market expectations.

Bull Confirmed If

An EPS of $0.12 or higher alongside revenue exceeding $101M would confirm a strong bull case.

Bear Confirmed If

An EPS below $0.01 or revenue falling short of $94M would support a bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±20.8%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings report.

Options are pricing ±20.2% while BLLN has averaged ±3.1% over the last 3 prints — setup is pricing rich.

Detail

ATM IV

1.4%

30d HV

88.9%

Calls (31K)P/C Ratio: 1.37Puts (6K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BillionToOne beats expectations, history suggests the stock could rise by around 3.72%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the market may react cautiously, leading to muted stock movement.

Miss

Should the company miss on earnings, history indicates a potential decline of about 4.65%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new genetic testing services being launched.
2Management's commentary on market demand and competitive positioning.
3Details on operational efficiency improvements and their impact on margins.
4Insights into customer acquisition strategies and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$0.06

Revenue

Revenue growth is crucial for assessing the company's overall performance and market demand for its services.

$97M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 3Q

EPS Beat Streak

EPS Beat Rate

67%

Avg EPS Surprise

+1110.58%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In the last quarter, BillionToOne reported an EPS of $0.11, significantly beating expectations. However, the stock experienced a decline of 2.78% the following day.

Management Promises & Guidance

Management committed to enhancing their genetic testing capabilities.
They expressed intentions to expand their market reach.
They highlighted plans to improve operational efficiency.

Expectations

Wall Street Expectations

Bull Case

If BillionToOne exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its services and lead to a positive stock reaction.

Bear Case

Conversely, if the company misses on EPS or revenue, it may raise concerns about its growth trajectory and impact investor confidence.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.06

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue

$97M

Revenue growth is crucial for assessing the company's overall performance and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.06?

A beat on EPS could reinforce investor confidence and support a bullish outlook for the company.

What revenue figures will BillionToOne report relative to the $97M consensus?

Revenue performance is critical for understanding market demand and growth potential, influencing future investor sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the company's growth potential, particularly if recent advancements in genetic testing lead to higher demand than anticipated.

Supporting Evidence

The last quarter's EPS surprise of +69.23% indicates stronger-than-expected performance.

The options market is pricing in a significant move, suggesting that traders expect volatility and potential upside.

BillionToOne's recent commitments to enhance testing capabilities could drive future growth.

Key Risk

If revenue comes in below $94M, it could challenge the optimistic growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's focus is on whether BillionToOne can sustain its growth momentum and meet or exceed market expectations.

Bull Confirmed If

An EPS of $0.12 or higher alongside revenue exceeding $101M would confirm a strong bull case.

Bear Confirmed If

An EPS below $0.01 or revenue falling short of $94M would support a bearish outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±20.8%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings report.

Options are pricing ±20.2% while BLLN has averaged ±3.1% over the last 3 prints — setup is pricing rich.

Detail

ATM IV

1.4%

30d HV

88.9%

Calls (31K)P/C Ratio: 1.37Puts (6K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BillionToOne beats expectations, history suggests the stock could rise by around 3.72%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the market may react cautiously, leading to muted stock movement.

Miss

Should the company miss on earnings, history indicates a potential decline of about 4.65%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new genetic testing services being launched.
2Management's commentary on market demand and competitive positioning.
3Details on operational efficiency improvements and their impact on margins.
4Insights into customer acquisition strategies and market expansion plans.